Pub. Date : 1997 Jun
PMID : 9204061
2 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
| 1 | OBJECTIVE: Our purpose was to evaluate the efficacy and safety of pentostatin in the treatment of patients with advanced and/or therapy-refractory CTCL. | Pentostatin | TSPY like 2 | Homo sapiens |
| 2 | CONCLUSION: Single-agent pentostatin in intravenous doses of 4 to 5 mg/m2 is an effective systemic treatment of CTCL (39% objective response rate) with little toxicity. | Pentostatin | TSPY like 2 | Homo sapiens |